Prelude Capital Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$37.38 - $49.47 $104,664 - $138,516
-2,800 Reduced 96.55%
100 $4,000
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $115,391 - $194,329
2,900 New
2,900 $127,000
Q2 2018

Aug 14, 2018
SELL
$23.62 - $42.29 $937,714 - $1.68 Million
-39,700 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$22.49 - $34.56 $892,852 - $1.37 Million
39,700 New
39,700 $1.02 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email